Immunogenicity of an Escherichia coli-produced bivalent human papillomavirus vaccine under different vaccination intervals.

Xiao-Juan Yu,Juan Li,Zhijie Lin,Hui Zhao,Bi-Zhen Lin,You-Lin Qiao,Yuemei Hu,Li Hui Wei,Rong Cheng Li,Wei Dan Huang,Ting Wu,Shou-Jie Huang,Changgui Li,Huirong Pan,Jun Zhang

Immunogenicity of an Escherichia coli-produced bivalent human papillomavirus vaccine under different vaccination intervals.

2020

Xiao-Juan Yu
Juan Li
Zhijie Lin
Hui Zhao
Bi-Zhen Lin
You-Lin Qiao
Yuemei Hu
Li Hui Wei
Rong Cheng Li
Wei Dan Huang
Ting Wu
Shou-Jie Huang
Changgui Li
Huirong Pan
Jun Zhang

A new Escherichia coli-produced human papillomavirus (HPV)-16/18 vaccine has been shown to be safe and highly efficacious and was recently licensed in China. As a post hoc analysis of the phase III...

Keywords:

Escherichia
Immunogenicity
antibody response
Escherichia coli
Medicine
human papillomavirus
Vaccination
Virology
Human papillomavirus vaccine
Bivalent (genetics)
Immunology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations